-
03-26
2022Clinofibrate, CAS:30299-08-2 新药中间体放大
Name：ClinofibrateFormulation：in 10mM DMSOTarget：HMG-CoA ReductasePathway：MetabolismInformation：Clinofibrate inhibits hydroxymethylglutaryl coenzyme A reduc -
03-26
2022Ciprofibrate, CAS:52214-84-3 线路优化
Name：CiprofibrateFormulation：in 10mM DMSOTarget：PPARPathway：DNA DamageInformation：Ciprofibrate is a peroxisome proliferator-activated receptor agonist.M.w. -
03-26
2022Trametinib (GSK1120212), CAS:871700-17-3 化合物优化
Name：Trametinib (GSK1120212)Formulation：in 10mM DMSOTarget：MEKPathway：MAPKInformation：Trametinib (GSK1120212) is a highly specific and potent MEK1/2 inhibi -
03-26
2022Ibrutinib (PCI-32765), CAS:936563-96-1 公斤级中间体
Name：Ibrutinib (PCI-32765)Formulation：in 10mM DMSOTarget：BTKPathway：AngiogenesisInformation：Ibrutinib (PCI-32765) is a potent and highly selective Brutons -
03-26
2022Dacomitinib (PF299804, PF299), CAS:1110813-31-4 大包装
Name：Dacomitinib (PF299804, PF299)Formulation：in 10mM DMSOTarget：EGFRPathway：Protein Tyrosine KinaseInformation：Dacomitinib (PF299804, PF299) is a potent, -
03-26
2022Fedratinib (SAR302503, TG101348), CAS:936091-26-8 工艺放大
Name：Fedratinib (SAR302503, TG101348)Formulation：in 10mM DMSOTarget：JAKPathway：JAK/STATInformation：Fedratinib (SAR302503, TG101348) is a selective inhibito -
03-26
2022Niraparib (MK-4827), CAS:1038915-60-4 线路优化
Name：Niraparib (MK-4827)Formulation：in 10mM DMSOTarget：PARPPathway：DNA DamageInformation：Niraparib (MK-4827) is a selective inhibitor of PARP1/2 with IC50 -
03-26
2022Canagliflozin, CAS:842133-18-0 化合物优化
Name：CanagliflozinFormulation：in 10mM DMSOTarget：SGLTPathway：GPCR & G ProteinInformation：Canagliflozin is a highly potent and selective SGLT2 inhibitor for -
03-26
2022Alectinib (CH5424802), CAS:1256580-46-7 公斤级
Name：Alectinib (CH5424802)Formulation：in 10mM DMSOTarget：ALKPathway：Protein Tyrosine KinaseInformation：Alectinib (CH5424802) is a potent ALK inhibitor with -
03-26
2022Tofacitinib (CP-690550,Tasocitinib), CAS:477600-75-2 小试供应
Name：Tofacitinib (CP-690550,Tasocitinib)Formulation：in 10mM DMSOTarget：JAKPathway：JAK/STATInformation：Tofacitinib (CP-690550,Tasocitinib) is a novel inhibi
